Sorting by

×

News Stay Update With Us

ConnectWise Appoints David Raissipour as the Chief Product and Technology Officer​ConnectWise Appoints David Raissipour as the Chief Product and Technology Officer GlobeNewswire

||
Industry vet will fulfill promise of delivering cutting-edge solutions to MSPs in the IT channel TAMPA, Fla., Nov. 25, 2024 (GLOBE NEWSWIRE) — ConnectWise, the leading software company dedicated...

KSD Miner Unveils Accessible Cloud Mining Platform for Passive Income Seekers​KSD Miner Unveils Accessible Cloud Mining Platform for Passive Income Seekers GlobeNewswire

||
London, UK, Nov. 25, 2024 (GLOBE NEWSWIRE) — KSD Miner, a recent entrant to the cloud mining industry, has launched a platform designed to simplify cryptocurrency mining for individuals...

PTX Metals Announces Upsizing of Non-Brokered Private Placement Financing to $3.0 Million​PTX Metals Announces Upsizing of Non-Brokered Private Placement Financing to $3.0 Million GlobeNewswire

||
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES....

Verizon advances its fiber network for AI workloads​Verizon advances its fiber network for AI workloads GlobeNewswire

||
Successful trial shows Verizon transporting 1.6 terabits per second of data across a single wavelength on its live metro fiber network BOSTON, Nov. 25, 2024 (GLOBE NEWSWIRE) — AI,...

CytoDyn Appoints Richard Pestell, M.D., Ph.D. as Lead Consultant in Oncology​CytoDyn Appoints Richard Pestell, M.D., Ph.D. as Lead Consultant in Oncology GlobeNewswire

||
VANCOUVER, Washington, Nov. 25, 2024 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple...

Pluri Evaluates Readiness for Mass Production of PLX-R18 for Acute Radiation Syndrome Amid Rising Nuclear Threat Concerns​Pluri Evaluates Readiness for Mass Production of PLX-R18 for Acute Radiation Syndrome Amid Rising Nuclear Threat Concerns GlobeNewswire

||
HAIFA, Israel, Nov. 25, 2024 (GLOBE NEWSWIRE) — Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a biotechnology company leveraging its proprietary platform for cell-based solutions to...

Cloudera’s Advanced AI Solutions Accelerate Global Humanitarian Aid for Mercy Corps​Cloudera’s Advanced AI Solutions Accelerate Global Humanitarian Aid for Mercy Corps GlobeNewswire

||
Partnering with Tech To The Rescue, Cloudera is improving decision-making and resource deployment for the global nonprofit Mercy Corps will join Cloudera at AWS re:Invent for a live demo...

Eterna Therapeutics Announces Up to $1 Million Stock Repurchase Program​Eterna Therapeutics Announces Up to $1 Million Stock Repurchase Program GlobeNewswire

||
CAMBRIDGE, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) — Eterna Therapeutics, Inc. (Nasdaq: ERNA), a leader in cell therapies, today announced that its Board of Directors has authorized a stock...